Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy

Cancer Research

Volumn 63, Issue 6, 2003, Pages 1242-1248

  Schimmer, Aaron D ^a   Pedersen, Irene Munk ^a   Kitada, Shinichi ^a   Eksioglu Demiralp, Emel ^a   Minden, Mark D ^b   Pinto, Ryan ^b   Mah, Ken ^b   Andreeff, Michael ^c   Kim, Youngsoo ^a   Suh, Won Suk ^a   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CYTARABINE; CYTOCHROME C; DAUNORUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPORATION; ENZYME ACTIVATION; ENZYME MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ADULT; AGED; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CYTOCHROME C GROUP; DRUG RESISTANCE, NEOPLASM; ELECTROPORATION; ENZYME ACTIVATION; GRANZYMES; HUMANS; K562 CELLS; LEUKEMIA, MYELOID; MIDDLE AGED; MITOCHONDRIA; OVALBUMIN; SERINE ENDOPEPTIDASES;

EID: 0037444287     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Bumett, A., and Goldstone, A. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1, 612 patients entered into the MRC AML 10 trial. Blood, 92: 2322-2333, 1998.
2. Kitada, S., Pedersen, I. M., Schimmer, A., and Reed, J. C. Dysregulation of apoptosis genes in hematopeietic malignancies. Oncogene, 21: 3459-3474, 2002.
3. Schimmer, A., Hedley, D. W., Penn, L. Z., and Minden, M. D. Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view. Blood, 98: 3541-3553, 2001.
4. Campos, L., Rouault, J. P., Sabido, O., Oriol, P., Roubi, N., Vasselon, C., Archimbaud, E., Magaud, J. P., and Guyotat, D. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response. Blood, 81: 3091-3096, 1993.
5. Bincoletto, C., Saad, S. T. O., Soares de Silva, E., and Queiroz, M. L. S. Haematopoietic response and bcl-2 expression in patients with acute myeloid leukaemia. Eur. J. Haematol., 62: 38-42, 1999.
6. Schaich, M., Illmer, T., Seitz, G., Mohr, B., Schakel, U., Beck, J. F., and Ehninger, G. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia. Haematologica, 86:470-477, 2001.
7. Wuchter. C., Karawajew, L., Ruppert, V., Schrappe, M., Harbott, J., Ratei, R., Dorken, B., and Ludwig, W. D. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia. Br. J. Haematol., 110: 154-160, 2000.
8. Coustan-Smith, E., Kitanaka, A., Pui, C. H., McNinch, L., Evans, W. E., Raimondi, S. C., Behm, F. G., Arico, M., and Campana, D. Clinical relevance of BCL-2 over-expression in childhood acute lymphoblastic leukemia. Blood, 87: 1140-1146, 1996.
9. Silva, J. M., Garcia, J. M., Dominguez, G., Silva, J., Rodriguez, R., Portero, J. L., Corbacho, C., Provencio, M., Espana, P., and Bonilla, F. DNA damage after chemotherapy correlates with tumor response and survival in small cell lung cancer patients. Mutat. Res., 456: 65-71, 2000.
10. Muller, M. R., Buschfort, C., J., T., Lensing, C., Rajewsky, M. F., and Seeber, S. DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia. Clin. Cancer Res., 3: 2055-2061, 1997.
11. Donovan, J. C., Milic, A., and Slingerland, J. M. Constitutive MEK/MAPK activation leads to p27(Kip1) deregulation and antiestrogen resistance in human breast cancer cells. J. Biol. Chem., 276: 40888-40895, 2001.
12. Banker, D. E., Groudine, M., Willman, C. L., Norwood, T., and Appelbaum, F. R. Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents. Leuk. Res., 22: 221-239, 1998.
13. Pedersen, I. M., Kitada, S., Schimmer, A., Kim, Y., Zapata, J. M., Charboneau, L., Rassenti, L., Andreeff, M., Bennett, F., Sporn, M., Liotta, L., Kipps, T. J., and Reed, J. C. The triterpenoid CDDO induces apoptosis in refractory CLL B-cells. Blood, 100: 2965-2972, 2002.
14. Zhou, Q., Snipas, S., Orth, K., Muzio, M., Dixit, V. M., and Salvesen, G. S. Target protease specificity of the viral serpin CrmA: analysis of five caspases. J. Biol. Chem., 272: 7797-7800, 1997.
15. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and Cytochrome C. Cell, 86: 147-157, 1996.
16. Deveraux, Q. L., Takahashi, R., Salvesen, G. S., and Reed, J. C. X-linked IAP is a direct inhibitor of cell death proteases. Nature (Lond.), 388: 300-304, 1997.
17. Bradford, M. M. A rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
18. Krajewski, S., Zapata, J. M., and Reed, J. C., Detection of multiple antigens on Western blots. Anal. Biochem., 236: 221-228, 1996.
19. Krajewska, M., Wang, H-G., Krajewski, S., Zapata, J. M., Shabaik, A., Gascoyne, R., and Reed, J. C. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res., 57: 1605-1613, 1997.
20. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
21. Reed, J. C. Mechanisms of apoptosis (Warner/Lambert Award). Am. J. Pathol., 157: 1415-1430, 2000.
22. Srinivasula, S. M., Hegde, R., Saleh, A., Datta, P., Shiozaki, E., Chai, J., Lee, R-A., Robbins, P. D., Fernandes-Alnemri, T., Shi, Y., and Alnermi, E. S. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature (Lond.), 410: 112-116, 2001.
23. Deveraux, Q. L., Leo, E., Stennicke, H. R., Welsh, K., Salvesen, G. S., and Reed, J. C. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J., 18: 5242-5251, 1999.
24. Jia, L., Srinivasula, S. M., Liu, F. T., Newland, A. C., Fernandes-Alnemri, T., Alnemri, E. S., and Kelsey, S. M. Apaf-protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood, 98: 414-421, 2001.
25. Kim, K. M., Lee, K., Hong, Y. S., and Park, H. Y. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells. Exp. Mol. Med., 32: 246-254, 2000.
26. Tamm, I., Komblau, S. M., Segall, H., Krajewski, S., Welsh, K., Kitada, S., Scudiero, D. A., Tudor, G., Qui, Y. H., Monks, A., Andreeff, M., and Reed, J. C. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin. Cancer Res., 6: 1796-1803, 2000.
27. Slovak, M. L., Kopecky, K. J., Cassileth, P. A., Harrington, D. H., Theil, K. S., Mohammed, A., Paietta, E., Willman, C. L., Head, D. R., Rowe, J. M., Forman, S. J., and Appelbaum, F. R. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastem Cooperative Oncology Group Study. Blood, 96: 4075-4083, 2000.
28. Quan, L. T., Tewari, M., O'Rourke, K., Dixit, V., Snipas, S. J., Poirier, G. G., Ray, C., Pickup, D. J., and Salvesen, G., Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc. Natl. Acad. Sci. USA, 93: 1972-1976, 1996.
29. Deveraux, Q. L., Roy, N., Stennicke, H. R., Van Arsdale, T., Zhou, Q., Srinivasula, M., Alnemri, E. S., Salvesen, G. S., and Reed, J. C. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J., 17: 2215-2223, 1998.
30. Estrov, Z., Thall, P. F., Talpaz, M., Estey, E. H., Kantarjian, H. M., Andreeff, M., Harris, D., Van, Q., Walterscheid, M., and Kornblau, S. M. Caspase 2 and Caspase 3 protein levels as predictors of survival in acute myelogenous leukemia. Blood, 92: 3090-3097, 1998.
31. Kornblau, S. M., Vu, H. T., Ruvolo, P., Estrov, Z., O'Brien, S., Cortes, J., Kantarjian, H., Andreeff, M., and May, W. S. Bax and PKCa modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia. Clin. Cancer Res., 6: 1401-1409, 2000.
32. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. SMAC, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102: 33-42, 2000.
33. Norgaard, J. M., Langkjer, S. T., Palshof, T., Clausen, N., Pedersen, B., and Hokland, P. Relation of blast cell survival and proliferation to chemotherapy resistance in AML. Br. J. Haematol., 93: 888-897, 1996.
34. Smith, B. D., Bambach, B. J., Vala, M. S., Barber, J. P., Enger, C., Brodsky, R. A., Burke, P. J., Gore, S. D., and Jones, R. J. Inhibited apoptosis and drug resistance in acute myeloid leukaemia. Br. J. Haematol., 102: 1042-1049, 1998.